- Press Release -

A recently revamped Fact.MR report forecasts that the global vaccine delivery devices market is projected to surge at a CAGR of 9.5% from 2022 to 2032, surpassing US$ 10 Bn by the end of the said assessment period. The market is primarily driven by the growing number of immunization programs, increasing initiatives for vaccination drives. Initiatives such as; GAVI Alliance, Bill & Melinda Gates Foundation have significantly benefitted the market.

From 2017 to 2021, the market expanded at a CAGR of 8%. Prospects further elevated during the COVID-19 pandemic, as it created an urgency for developed and efficient vaccination devices, thereby elevating the market size. In addition, the initiatives taken by various governments and non-government organizations are anticipated to boost the market significantly.

For instance, the UK government invested £1 million from its Global Challenges Research Fund through Medical Research Council to probe the Zika Virus transmission and its source. In addition, the demand for advanced vaccine delivery devices has increased owing to their application in treatments of influenza, hepatitis A and B, and meningitis, thereby bolstering the market size in the forecast period.

Key Takeaways from the Market Study

• By product type, syringes are likely to be most lucrative, accumulating US$ 900 Mn in value
• Sales of intramuscular vaccine delivery devices to reach a value of US$ 1 Bn by 2022
• North America to be a potential revenue hub, forecast to incline at a 10% CAGR
• APEJ to be the most opportunistic market, flourishing at 12% CAGR from 2022-2032
• Global vaccine delivery devices market likely to be valued at over US$ 4 Bn by 2022-end

“Increasing usage of vaccine delivery devices in the healthcare sector for the treatment of influenza, meningitis, and hepatitis A and B is anticipated to provide a significant boost to the market in the coming time. “ – says an analyst at Fact MR.

Competitive Landscape

Key players of the global vaccine delivery devices adopt various strategies to acquire a forefront position in the market. Strategies such as; acquisitions, partnerships, and collaborations are some of the methods used to enhance their footprints in the global market. Some of the recent developments among the key players are:

• In August 2021, the Vaccine developer Serum Institute of India acquired a 50% stake in pharma packaging company Schott Kaisha. Schott AG is a Germany-based player that manufactures vials, syringes, and cartridges.
• In April 2020, Zealand Pharma acquired Valeritas Holdings, a U.S based key player, for a price of USD 23 Mn.

• In November 2021, Gerresheimar announced a partnership with Midas Pharma for a new auto injector. The partnership boosts the development and marketing of new generation auto injector.

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the medical vaccine delivery devices market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of product (syringes, jet injectors and others), route of administration (subcutaneous, intramuscular intradermal and others) across six regions (North America, Latin America, Europe, Japan, APEJ and Middle Eats & Africa).

Fact.MR’s Domain Knowledge in Healthcare

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

For more information, refer to our market research report or contact the PR author.

Shambhu Nath Jha

Fact.MR

Sr. Consultant - Healthcare

E-mail: shambhu@factmr.com